Neutrophil to lymphocyte ratio (NLR) as a predictor of outcomes in patients with urothelial carcinoma (UC) treated with immune checkpoint inhibitors (ICI)

Checkpoint Inhibitors ◽

Neutrophil to lymphocyte ratio (NLR) as a predictor of outcomes in patients with urothelial carcinoma (UC) treated with immune checkpoint inhibitors (ICI)

European Urology Supplements ◽

10.1016/s1569-9056(19)31529-5 ◽

2019 ◽

Vol 18 (1) ◽

pp. e2110-e2111 ◽

Cited By ~ 1

Author(s):

A. Soualhi ◽

R. Kieran ◽

C. Moss ◽

D. Enting ◽

S. Hughes ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

777P Decrease in derived neutrophil-to-lymphocyte ratio (dNLR) related to immune checkpoint inhibitors (ICI) benefit in patients with metastatic urothelial carcinoma (mUC)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.849 ◽

2020 ◽

Vol 31 ◽

pp. S596-S597

Author(s):

H.K. Oberoi ◽

L. Ghiglione ◽

T. Gorría Puga ◽

L. Fernández Mañas ◽

L. Ferrer Mileo ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Lymphocyte Ratio ◽

Metastatic Urothelial Carcinoma

Neutrophil–to–lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Anticancer Research ◽

10.21873/anticanres.13765 ◽

2019 ◽

Vol 39 (10) ◽

pp. 5675-5682 ◽

Cited By ~ 4

Author(s):

JHE-CYUAN GUO ◽

CHIA-CHI LIN ◽

CHEN-YUAN LIN ◽

MIN-SHU HSIEH ◽

HUNG-YANG KUO ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

1296P Immune checkpoint inhibitors with or without bone targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1898 ◽

2021 ◽

Vol 32 ◽

pp. S1004-S1005

Author(s):

A. Bongiovanni ◽

F. Foca ◽

J. Menis ◽

L.S. Stucci ◽

F. Artioli ◽

...

Keyword(s):

Targeted Therapy ◽

Bone Metastases ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Prognostic Significance ◽

Lymphocyte Ratio ◽

Nsclc Patients

Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases

Scientific Reports ◽

10.1038/s41598-021-96915-2 ◽

2021 ◽

Vol 11 (1) ◽

Author(s):

Adam Lauko ◽

Bicky Thapa ◽

Mayur Sharma ◽

Baha’eddin A. Muhsen ◽

Addison Barnett ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Pretreatment Neutrophil-to-Lymphocyte Ratio as a Predictor of Survival and Response to Therapy in Patients Treated with Immune Checkpoint Inhibitors

SSRN Electronic Journal ◽

10.2139/ssrn.3578798 ◽

2020 ◽

Author(s):

Cristina Valero ◽

Mark Lee ◽

Douglas Hoen ◽

Kate Weiss ◽

Daniel Kelly ◽

...

Keyword(s):

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Response To Therapy ◽

Early neutrophil to lymphocyte ratio dynamics to predict progression free survival in patients treated with immune-checkpoint inhibitors.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e14513 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e14513-e14513

Author(s):

Michele Moschetta ◽

Benjamin Kasenda ◽

Gabriel Mak ◽

Mark Voskoboynik ◽

Nataliya Martynyuk ◽

...

Keyword(s):

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Progression Free Survival ◽

Free Survival ◽

Pre-therapy neutrophil-to-lymphocyte ratio and lymphocyte-to-monocyte ratio do not predict survival in patients treated with immune checkpoint inhibitors.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e15092 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e15092-e15092 ◽

Cited By ~ 1

Author(s):

Hashim Mann ◽

Muhammad Umair Mushtaq ◽

Xavier Alberto Andrade Gonzalez ◽

Ahmed T Ahmed ◽

Shweta Gupta

Keyword(s):

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Lymphocyte Ratio ◽

Lymphocyte To Monocyte Ratio

High pretreatment neutrophil-to-lymphocyte ratio (NLR) and its reactive increase as better predictors of poor clinical outcomes compared to tumor mutation burden (TMB) in solid tumor patients treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e24109 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e24109-e24109

Author(s):

Vaia Florou ◽

Wungki Park ◽

Alfredo Enrique Torres ◽

Sandra Algaze ◽

Diana Saravia ◽

...

Keyword(s):

Clinical Outcomes ◽

Solid Tumor ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Tumor Patients ◽

Tumor Mutation Burden ◽

Lymphocyte Ratio ◽

Mutation Burden

Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis

OncoTargets and Therapy ◽

10.2147/ott.s153290 ◽

2018 ◽

Vol Volume 11 ◽

pp. 955-965 ◽

Cited By ~ 84

Author(s):

Danielle Benedict Sacdalan ◽

Josephine Anne Lucero ◽

Dennis Sacdalan

Keyword(s):

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis ◽

Lymphocyte Ratio ◽

Prognostic Utility